Literature DB >> 9484982

Peripheral arterial disease in the elderly: The Rotterdam Study.

W T Meijer1, A W Hoes, D Rutgers, M L Bots, A Hofman, D E Grobbee.   

Abstract

To assess the age- and sex-specific prevalence of peripheral arterial disease (PAD) and intermittent claudication (IC) in an elderly population, we performed a population-based study in 7715 subjects (40% men, 60% women) aged 55 years and over. The presence of PAD and IC was determined by measuring the ankle-arm systolic blood pressure index (AAI) and by means of the World Health Organization/Rose questionnaire, respectively. PAD was considered present when the AAI was <0.90 in either leg. The prevalence of PAD was 19.1% (95% confidence interval, 18.1% to 20.0%): 16.9% in men and 20.5% in women. Symptoms of IC were reported by 1.6% (95% confidence interval, 1.3% to 1.9%) of the study population (2.2% in men, 1.2% in women). Of those with PAD, 6.3% reported symptoms of IC (8.7% in men, 4.9% in women), whereas in 68.9% of those with IC an AAI below 0.90 was found. Subjects with an AAI <0.90 were more likely to be smokers, to have hypertension, and to have symptomatic or asymptomatic cardiovascular disease compared with subjects with an AAI of 0.90 or higher. The authors conclude that the prevalence of PAD in the elderly is high whereas the prevalence of IC is rather low, although both prevalences clearly increase with advancing age. The vast majority of PAD patients reports no symptoms of IC.

Entities:  

Mesh:

Year:  1998        PMID: 9484982     DOI: 10.1161/01.atv.18.2.185

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  128 in total

1.  Determinants of locomotor disability in people aged 55 years and over: the Rotterdam Study.

Authors:  E Odding; H A Valkenburg; H J Stam; A Hofman
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study.

Authors:  Kathryn A Britton; Kenneth J Mukamal; Joachim H Ix; David S Siscovick; Anne B Newman; Ian H de Boer; Evan L Thacker; Mary L Biggs; J Michael Gaziano; Luc Djoussé
Journal:  Vasc Med       Date:  2012-03-08       Impact factor: 3.239

3.  Walking exercise in patients with intermittent claudication. Experience in routine clinical practice.

Authors:  Marie-Louise Bartelink; Henri E J H Stoffers; Cornelis J Biesheuvel; Arno W Hoes
Journal:  Br J Gen Pract       Date:  2004-03       Impact factor: 5.386

4.  Approach to lipid therapy in the patient with atherosclerotic vascular disease.

Authors:  Reena L Pande
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

5.  Multiparametric assessment of vascular function in peripheral artery disease: dynamic measurement of skeletal muscle perfusion, blood-oxygen-level dependent signal, and venous oxygen saturation.

Authors:  Erin K Englund; Michael C Langham; Sarah J Ratcliffe; Molly J Fanning; Felix W Wehrli; Emile R Mohler; Thomas F Floyd
Journal:  Circ Cardiovasc Imaging       Date:  2015-04       Impact factor: 7.792

Review 6.  Statin therapy in cardiovascular diseases other than atherosclerosis.

Authors:  Dominique Beaudry; Kenneth E Stone; Suzanne Wetherold; John Hemphill; Dat Do; John McClish; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

Review 7.  Peripheral arterial disease.

Authors:  Kevin Cassar
Journal:  BMJ Clin Evid       Date:  2007-07-01

Review 8.  Ace inhibitors as a therapy for sarcopenia - evidence and possible mechanisms.

Authors:  D Sumukadas; M D Witham; A D Struthers; M E T McMurdo
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

9.  The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model.

Authors:  Kelly P Downing; Kevin T Nead; Yoko Kojima; Themistocles Assimes; Lars Maegdefessel; Thomas Quertermous; John P Cooke; Nicholas J Leeper
Journal:  Vasc Med       Date:  2013-12-09       Impact factor: 3.239

10.  Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Michael R Jaff; Anthony J Comerota; Michael W Steffes; Ingrid H Abrahamsen; Suzanne Goldberg; Alan T Hirsch
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.